These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11523556)

  • 1. Structure-activity relationships of ketolides vs. macrolides.
    Douthwaite S
    Clin Microbiol Infect; 2001; 7 Suppl 3():11-7. PubMed ID: 11523556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site.
    Douthwaite S; Champney WS
    J Antimicrob Chemother; 2001 Sep; 48 Suppl T1():1-8. PubMed ID: 11566971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ketolides: a critical review.
    Zhanel GG; Walters M; Noreddin A; Vercaigne LM; Wierzbowski A; Embil JM; Gin AS; Douthwaite S; Hoban DJ
    Drugs; 2002; 62(12):1771-804. PubMed ID: 12149046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Will resistance to ketolides develop in Streptococcus pneumoniae?
    Leclercq R
    J Infect; 2002 Feb; 44 Suppl A():11-6. PubMed ID: 12150490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiological profile of telithromycin, the first ketolide antimicrobial.
    Felmingham D
    Clin Microbiol Infect; 2001; 7 Suppl 3():2-10. PubMed ID: 11523558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
    Garza-Ramos G; Xiong L; Zhong P; Mankin A
    J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multicenter study in southern South America of the in vitro activity of telithromycin in strains with defined resistance phenotypes isolated from community-acquired respiratory infections].
    Casellas JM; Visser M; Mac Dougall N; Coco B; Tomé G; Gliosca L;
    Rev Esp Quimioter; 2001 Sep; 14(3):269-74. PubMed ID: 11753448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging new generation of antibiotic: ketolides.
    Zhong P; Shortridge V
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):125-31. PubMed ID: 12455409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide.
    Ackermann G; Rodloff AC
    J Antimicrob Chemother; 2003 Mar; 51(3):497-511. PubMed ID: 12615850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of macrolides and ketolides: focus on respiratory tract infections.
    Zhanel GG; Dueck M; Hoban DJ; Vercaigne LM; Embil JM; Gin AS; Karlowsky JA
    Drugs; 2001; 61(4):443-98. PubMed ID: 11324679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketolides-telithromycin, an example of a new class of antibacterial agents.
    Bryskier A
    Clin Microbiol Infect; 2000 Dec; 6(12):661-9. PubMed ID: 11284926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telithromycin: the first ketolide antibacterial for the treatment of community-acquired respiratory tract infections.
    Lorenz J
    Int J Clin Pract; 2003; 57(6):519-29. PubMed ID: 12918892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
    Douthwaite S; Hansen LH; Mauvais P
    Mol Microbiol; 2000 Apr; 36(1):183-93. PubMed ID: 10760175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycin.
    Leclercq R
    J Antimicrob Chemother; 2001 Sep; 48 Suppl T1():9-23. PubMed ID: 11566972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of the new ketolide telithromycin and other antibiotics against Streptococcus pneumoniae in Belgium.
    Verhaegen J; Verbist L
    Acta Clin Belg; 2001; 56(6):349-53. PubMed ID: 11881319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telithromycin: a brief review of a new ketolide antibiotic.
    Scheinfeld N
    J Drugs Dermatol; 2004; 3(4):409-13. PubMed ID: 15303785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Ketolides in Treatment of Upper Respiratory Tract Infections.
    Zhanel GG; Wierzbowski AK; Hisanaga P; Hoban DJ
    Curr Infect Dis Rep; 2004 Jun; 6(3):191-199. PubMed ID: 15142482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telithromycin: the first of the ketolides.
    Shain CS; Amsden GW
    Ann Pharmacother; 2002 Mar; 36(3):452-64. PubMed ID: 11895060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.